A single-arm exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma.

被引:0
|
作者
Zhu, Wenyu
Chu, Yunqian
He, Xuan
Jiang, Hua
Zhu, Chan
Zhang, Xing
Wu, Fangfang
Dai, Hanjue
Xian, Qingying
Xue, Ya
机构
[1] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Oncol, Changzhou, Jiangsu, Peoples R China
[2] Dalian Med Univ, Grad Sch, Dalian, Peoples R China
[3] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Jiangsu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16008
引用
收藏
页数:1
相关论文
共 50 条
  • [21] First-line of penpulimab and chemotherapy for advanced non-melanoma cutaneous carcinoma: A single center, single arm, exploratory study
    Xu, Jing
    Zhu, Dongyuan
    Liu, Zengjun
    Cui, Jinfang
    Liu, Mengyao
    Hu, Wenyu
    Xu, Ni
    Li, Minghuan
    Fu, Heng
    Zhao, Junkai
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial
    Pan, Lanlan
    Tian, Yitong
    Wang, Kangxin
    Tang, Jie
    Liu, Jin
    Zhang, Jiaguang
    Wang, Min
    Liu, Jie
    Xu, Hao
    Chen, Xiaofeng
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 3300 - 3313
  • [23] Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/ gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial
    Pan, Lanlan
    Tian, Yitong
    Wang, Kangxin
    Tang, Jie
    Liu, Jin
    Zhang, Jiaguang
    Wang, Min
    Liu, Jie
    Xu, Hao
    Chen, Xiaofeng
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (06) : 3300 - 3313
  • [24] Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study
    Hao, Chunyi
    Du, Chengyou
    Peng, Baogang
    Zhang, Wu
    Shan, Yunfeng
    Lv, Ang
    Wu, Jianhui
    Shang, Changzhen
    Luo, Xuan
    Wei, Jinxing
    Xiao, Heng
    Qiu, Jianguo
    Hua, Yunpeng
    Shen, Shunli
    Wang, Ting
    Dai, Shengjie
    Chen, Xiang
    Yan, Shican
    Hao, Chunyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [25] A Single-Arm Phase II Study of Anlotinib Combined with Pemetrexed plus Cisplatin as a First-Line Therapy in Advanced NSCLC
    Xiong, J.
    Li, J.
    Deng, J.
    Zhang, W.
    Wang, H.
    Zeng, L.
    Shi, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S675 - S676
  • [26] Effect of autologous lymphocytes combined with chemotherapy as the first-line treatment of advanced gastric cancer
    Ma, Xiaoting
    Yang, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] First-line treatment of camrelizumab combined with chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma: Study protocol for a prospective, multicenter, phase II study
    Li, Xiaofen
    Ma, Qing
    Chang, Chen
    Li, Hao
    Cao, Dan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Clinical study on the second-line treatment of advanced esophageal squamous cell carcinoma with camrelizumab combined with apatinib and irinotecan: A single-arm, multicenter, phase II study
    He, Yifu
    Li, Chenghui
    Zhang, Fenglin
    Hu, Bing
    Sun, Yubei
    Xia, Xiaoyang
    Zhang, Yanshun
    Wang, Gang
    Xu, Tengyun
    Duan, Aixiong
    Wu, Shusheng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [29] Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma
    Zhang, Bo
    Qi, Ling
    Wang, Xi
    Xu, Jianping
    Liu, Yun
    Mu, Lan
    Wang, Xingyuan
    Bai, Lidan
    Huang, Jing
    CANCER COMMUNICATIONS, 2020, 40 (12) : 711 - 720
  • [30] Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory study
    Zhao, Shen
    Fan, Nanfeng
    Li, Hui
    Liu, Jie
    Huang, Feng
    Chen, Yigui
    Zhou, Min
    Yu, Jiaqing
    Lin, Rongbo
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (19)